Literature DB >> 1131426

The effect of azathioprine (Imuran) on the kinetics of monocytes and macrophages during the normal steady state and an acute inflammatory reaction.

A E Gassmann, R van Furth.   

Abstract

The effect of azathioprine on the kinetics of peripheral blood monocytes and peritoneal macrophages was studied in normal mice and in mice in which an inflammatory reaction was provoked. Two dosage levels were used: a high dose of 200mg/kg which is the maximum tolerated daily dose in mice, and low dose of 3 mg/kg which is about equivalent to a nontoxic, immunosuppressive, anti-inflammatory dose in man. The number of peripheral blood monocytes decreases gradually during azathioprine treatment of normal mice, the extent and duration being dependent on the dose and duration of administered over a period of 9 days gives an almost complete reduction, and a low dose (3 mg/kg) given for the same period results in a reduction of about 50%. This effect seems to be reversible, because when treatment is stopped the number of monocytes starts to increase 24-48 hr later. The number of peritoneal macrophages is only affected when a high dose (200 mg/kg) is given over a long period; a low dose has virtually no effect. In mice in which an inflammatory reaction was prevoked in the peritoneal cavity, the normally occurring increase in the numbers of both peripheral blood monocytes and peritoneal macrophages was suppressed, the extent being dependent on the dose of azathioprine administered. Labeling studies with 3H-thymidine indicated that the reduction of peripheral blood monocytes and peritoneal macrophages in the inflammatory exudate is due to a diminished monocyte production.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1131426

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  The effect of azathioprine on cell-mediated immunity (CMI) to Candida albicans in Crohn's disease.

Authors:  G M Gyte; J M Willoughby
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

Review 2.  Treatment of vasculitis.

Authors:  H G Taylor; A Samanta
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

Review 3.  Macrophage activation, chronic inflammation and gastrointestinal disease.

Authors:  A R Tanner; M J Arthur; R Wright
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

Review 4.  Therapeutic Strategies for Immune Transformation in Parkinson's Disease.

Authors:  Maamoon Saleh; Milica Markovic; Katherine E Olson; Howard E Gendelman; R Lee Mosley
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

5.  Effect of irradiation, cyclophosphamide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction.

Authors:  J W van't Wout; I Linde; P C Leijh; R van Furth
Journal:  Inflammation       Date:  1989-02       Impact factor: 4.092

6.  The effect of a protein-bound polysaccharide from Coriolus versicolor on immunological parameters and experimental infections in mice.

Authors:  P Mayer; J Drews
Journal:  Infection       Date:  1980       Impact factor: 3.553

7.  Lymph node macrophages: drug-related reaction or infectious-lesion?

Authors:  Adriana Handra-Luca
Journal:  Intest Res       Date:  2018-10-25

8.  Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancer.

Authors:  Preethi Korangath; James D Barnett; Anirudh Sharma; Elizabeth T Henderson; Jacqueline Stewart; Shu-Han Yu; Sri Kamal Kandala; Chun-Ting Yang; Julia S Caserto; Mohammad Hedayati; Todd D Armstrong; Elizabeth Jaffee; Cordula Gruettner; Xian C Zhou; Wei Fu; Chen Hu; Saraswati Sukumar; Brian W Simons; Robert Ivkov
Journal:  Sci Adv       Date:  2020-03-25       Impact factor: 14.136

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.